Search

Your search keyword '"Dog Diseases blood"' showing total 4,027 results

Search Constraints

Start Over You searched for: Descriptor "Dog Diseases blood" Remove constraint Descriptor: "Dog Diseases blood" Database MEDLINE Remove constraint Database: MEDLINE
4,027 results on '"Dog Diseases blood"'

Search Results

1. Involvement of canine parvovirus in mRNA expression levels of key lectins and caspases in blood leukocytes.

2. Whole blood gene expression analysis of spontaneous hypertriglyceridemia in dogs suggests an underlying pro-thrombotic process.

3. Comparative performance analysis of different microfilaria testing methods for Dirofilaria immitis in canine blood.

4. Iron deficiency in dogs suffering from atopic dermatitis.

5. Correlation of serum chloride concentrations with components of the renin-angiotensin-aldosterone system in a dog with congestive heart failure.

6. Standard tests of haemostasis do not predict elevated thromboelastographic maximum amplitude, an index of hypercoagulability, in sick dogs.

7. Nesfatin-1 expression and blood plasma concentration in female dogs suffering from cystic endometrial hyperplasia and pyometra and its possible interaction with phoenixin-14.

8. Clinical significance of blood cell ratios in healthy and sick Leishmania infantum-seropositive dogs.

9. Dogs may carry Leishmania tropica and Leishmania major in their blood circulation: a molecular and hematological study.

10. Assessment of the circulating inflammatory mediator interleukin-8 in dogs with tracheal collapse.

11. Low serum adiponectin levels are associated with an increased risk of diabetes in obese dogs.

12. Evaluating preoperative coagulation panels in dogs undergoing liver lobectomy for primary liver tumors: A multi-institutional retrospective study.

13. Spatiotemporal analysis and clinico-epidemiological study for seroprevalence of canine leptospirosis.

14. Genomic profiling of cell-free DNA from dogs with benign and malignant tumors.

15. KC-like chemokine as a biomarker of sepsis in dogs with pyometra.

16. Evaluation serum soluble interleukin 2 receptor with diagnosis and prognosis in canine solid tumour: 34 cases.

17. Relapse Risk Factors for Immune-Mediated Hemolytic Anemia: A Retrospective Study of 163 Dogs.

18. Evaluation of a whole blood point-of-care coagulation analyzer in dogs.

19. Characterization of the circulating markers of the renin-angiotensin-aldosterone system in telmisartan- or enalapril-treated dogs with proteinuric chronic kidney disease.

20. Elevated serum gamma-glutamyltransferase activity and immunohistochemistry in two dogs with renal carcinoma.

21. The association between taurine concentrations and dog characteristics, clinical variables, and diet in English cocker spaniels: The Canine taURinE (CURE) project.

22. Dysregulated serum concentrations of fat-soluble vitamins in dogs with chronic enteropathy.

23. Assessment of cell cycle arrest biomarkers and neutrophil gelatinase-associated lipocalin to distinguish acute kidney injury from other diseases in dogs.

24. Comparison of fibroblast growth factor 19 concentrations between dogs with and without gallbladder mucoceles.

25. Plasma concentration of thrombopoietin in dogs with immune thrombocytopenia.

26. Enhancing electrochemical detection through machine learning-driven prediction for canine mammary tumor biomarker with green silver nanoparticles.

27. Molecular detection and phylogenetic analysis of Borrelia Spp. In blood samples of cats and dogs by the nested-PCR method in West Azerbaijan Province, Iran.

28. Pilot study to evaluate isolation by size of circulating tumour cells in canine oral melanoma.

29. Determination of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and systemic immune-inflammation index in dogs with leptospirosis.

30. Circulating nucleosomes as a potential cancer biomarker in dogs with splenic nodular lesions.

31. Blood Neutrophil-to-Lymphocyte Ratio as a Potential Prognostic Marker in Dogs ≤10 kg With Multicentric Lymphoma.

32. Evaluation of clopidogrel, hypercoagulability, and platelet count in dogs undergoing splenectomy for splenic masses.

33. DR-70 (fibrinogen-fibrin degradation products) as a prognostic biomarker in dogs with neoplasms.

34. Serum and urinary monocyte chemoattractant protein-1 as markers of inflammation and renal damage in dogs with naturally occurring leishmaniosis.

35. Characterization of faecal microbiota and serum inflammatory markers in dogs diagnosed with chronic enteropathy or small-cell lymphoma: a pilot study.

36. Molecular identification of haemoparasites in animals using blood lysate PCR: a quick and inexpensive alternative to purified whole genomic DNA.

37. Neutrophil-to-lymphocyte ratio and red blood cell distribution width to platelet ratio and their relationships with inflammatory and antioxidant status in dogs with different stages of heart failure due to myxomatous mitral valve disease.

38. Changes in biomarkers of the redox status in whole blood and red blood cell lysates in canine hypothyroidism.

39. Agreement between lacrimal fluid and serum for detecting urea nitrogen and creatinine in dogs.

40. Strain-level variations of Dirofilaria immitis microfilariae in two biochemical assays.

41. Evaluation of the effect of fresh-frozen plasma transfusion on circulating hyaluronic acid concentration in critically ill dogs: a pilot study.

42. A veterinary-calibrated point-of-care glucometer accurately measures blood glucose concentration in dogs and cats.

43. Longitudinal analysis of echocardiographic and cardiac biomarker variables in dogs with atrial fibrillation: The optimal rate control in dogs with atrial fibrillation II study.

44. Can neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios be used as markers for hypercortisolism in dogs?

45. Perioperative changes in plasma cardiac troponin I concentration during mitral valvuloplasty for severe mitral regurgitation in dogs.

46. Vitamin D status in female dogs with mammary gland tumors.

47. Studies on the association of malondialdehyde as a biomarker for oxidative stress and degree of malignancy in dogs with mammary adenocarcinomas.

48. Factors influencing serum concentrations of levetiracetam in dogs with epilepsy.

49. Trace element status in canine endocrine diseases.

50. Serosurvey for Canine Influenza in Coyotes (Canis latrans) in Illinois, USA, 2000-23.

Catalog

Books, media, physical & digital resources